APA (7th ed.) Citation

Wiendl, H., Gold, R., Berger, T., Derfuss, T., Linker, R., Mäurer, M., . . . Zipp, F. (2021). Multiple Sclerosis Therapy Consensus Group (MSTCG): Position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders, 14, 17562864211039648. https://doi.org/10.1177/17562864211039648

Chicago Style (17th ed.) Citation

Wiendl, Heinz, et al. "Multiple Sclerosis Therapy Consensus Group (MSTCG): Position Statement on Disease-modifying Therapies for Multiple Sclerosis (white Paper)." Therapeutic Advances in Neurological Disorders 14 (2021): 17562864211039648. https://doi.org/10.1177/17562864211039648.

MLA (9th ed.) Citation

Wiendl, Heinz, et al. "Multiple Sclerosis Therapy Consensus Group (MSTCG): Position Statement on Disease-modifying Therapies for Multiple Sclerosis (white Paper)." Therapeutic Advances in Neurological Disorders, vol. 14, 2021, p. 17562864211039648, https://doi.org/10.1177/17562864211039648.